Financhill
Back

Ultragenyx Pharmaceutical Vs. Perspective Therapeutics Industry Stock Comparison

Sell
44

RARE
Ultragenyx Pharmaceutical

Last Price:
45.15
Seasonality Move:
-7.5%
Buy
61

CATX
Perspective Therapeutics

Last Price:
12.92
Seasonality Move:
2.26%
Sell
44
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $45.14. The Score for RARE is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Perspective Therapeutics (CATX) is a Buy

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $12.91. The Score for CATX is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • CATX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $45.14
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $12.91
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.62 Buy
Relative Strength Index (14 RSI): 66.39 Buy
Chaikin Money Flow: 779842 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.34 - 42.98) Buy
Bollinger Bands (100): (40.31 - 48.45) Buy

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.36 Sell
Relative Strength Index (14 RSI): 57.56 Buy
Chaikin Money Flow: 1027595 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.07 - 12.31) Buy
Bollinger Bands (100): (10.44 - 15.8) Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 42.16 Buy
20-day SMA: 40.88 Buy
50-day SMA: 41.15 Buy
200-day SMA: 42.67 Buy
8-day EMA: 42.68 Buy
20-day EMA: 41.65 Buy
50-day EMA: 41.88 Buy
200-day EMA: 43.2 Buy

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.27 Buy
20-day SMA: 10.79 Buy
50-day SMA: 13.57 Sell
200-day SMA: 8.6 Buy
8-day EMA: 11.52 Buy
20-day EMA: 11.46 Buy
50-day EMA: 12.39 Buy
200-day EMA: 10.02 Buy

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):